The Chase Group is pleased to announce the placement of the Vice President, Immuno-Oncology Global & US Medical Affairs for Eli Lilly. The successful candidate…
Continue Reading →
Lilly Oncology is known for its exciting pipeline across multiple tumor types and dedication to addressing the unmet needs of people living with cancer. Their…
Continue Reading →
The Chase Group is pleased to announce the successful completion of the Vice President, US and Global Medical Affairs at Eli Lilly. The new Vice…
Continue Reading →
As a leader in engineering human enzymes to address significant unmet medical needs in rare genetic diseases and cancer, Aeglea BioTherapeutics is committed to using…
Continue Reading →
The Chase Group is pleased to announce our recent partnership and executive search engagement with the international biopharmaceutical company, Immunovative Therapies, Ltd. (ITL), currently headquartered…
Continue Reading →
The Chase Group is pleased to announce our latest placement for Ionis Pharmaceuticals. Due to exciting organizational growth, Ionis welcomes a new Associate Director, Investor…
Continue Reading →
The Chase Group is pleased to announce the successful completion of the Vice President, Global Head of Data Sciences search at Genmab. A scientist with…
Continue Reading →
As Genmab continues its expansion into full product development, the need for high caliber talent is essential in executing their mission to create and develop…
Continue Reading →
The Chase Group is pleased to announce our recent partnership and executive search engagement with the highly-respected Allen Institute in Seattle, Washington. Devoted to unlocking…
Continue Reading →
The Chase Group is pleased to announce the successful completion of the Director, Clinical Research, Neuroscience at Eisai Inc. The successful candidate is a Board…
Continue Reading →